Inflammation and glucose intolerance: A prospective study of gestational diabetes mellitus

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 21-27

  Wolf, Myles ^a   Sauk, Jenny ^a   Shah, Anand ^a   Smirnakis, Karen Vossen ^a   Jimenez Kimble, Ricardo ^a   Ecker, Jeffrey L ^a   Thadhani, Ravi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PROSPECTIVE STUDY; SCREENING TEST; THIRD TRIMESTER PREGNANCY;

ADULT; BIRTH WEIGHT; BLOOD PRESSURE; BOSTON; CESAREAN SECTION; DELIVERY, OBSTETRIC; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; GLUCOSE INTOLERANCE; HUMANS; INFANT, NEWBORN; INFLAMMATION; PREGNANCY; PROSPECTIVE STUDIES;

EID: 1042291863     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.21     Document Type: Article

References (46)

1. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Bethesda, MD, National Institutes of Health, National Heart, Lung, and Blood Institute, 2000, p. 1-38 (NIH publ. no. 00-3029)
2. Buchanan TA, Kjos SL: Gestational diabetes: risk or myth? J Endocrinol Metab 84:1854-1857, 1999
3. Verma A, Boney CM, Tucker R, Vohr BR: Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Endocrinol Metab 87:3227-3235, 2002
4. Meyers-Seifer CH, Vohr BR: Lipid levels in former gestational diabetic mothers. Diabetes Care 19:1351-1356, 1996
5. Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT: Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 24:1764-1769, 2001
6. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A: Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 25:560-564, 2002
7. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200, 2001
8. Buchanan TA: Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989-993, 2001
9. Catalano PM, Huston L, Amini SB, Kalhan SC: Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903-916, 1999
10. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, Sims EA: Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264:E60-E67, 1993
11. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000
12. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA: High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455-461, 2002
13. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA: Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 161:233-242, 2002
14. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
15. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1998
16. Hotamisligil GS: Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 107:119-125, 1999
17. Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K: Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity (Letter). Diabetologia 41:860-861, 1998
18. Senn JJ, Klover PJ, Nowak IA, Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399, 2002
19. Radon PA, McMahon MJ, Meyer WR: Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 94:194-197, 1999
20. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N: Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453-2455, 2001
21. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P: Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 86:1306-1312, 2001
22. Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P: Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazonc in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Clin Endocrinol Mctab 86:3250-3256, 2001
23. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799-1804, 2003
24. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809, 2002
25. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H: The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27:443-449, 2003
26. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W: Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835-1839, 2000
27. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM is a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
28. Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM: C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 23:650-655, 2003
29. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000
30. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM: TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213, 2002
31. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R: First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819-824, 2003
32. Matthews JN, Altman DG, Campbell MJ, Royston P: Analysis of serial measurements in medical research. BMJ 300:230-235, 1990
33. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
34. Kjos SL, Buchanan TA: Gestational diabetes mellitus. N Engl J Med 341:1749-1756, 1999
35. Friedman GD, Selby JV, Quesenberry CP Jr: The leukocyte count: a predictor of hypertension. J Clin Epidemiol 43:907-911, 1990
36. Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K: White blood cell count as a risk factor for hypertension: a study of Japanese male office workers. J Hypertens 20:851-857, 2002
37. Pickup JC, Crook MA: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241-1248, 1998
38. Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, Pinkney J: beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 86:5864-5869, 2001
39. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML: Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 23:303-310, 2000
40. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W: Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520, 2000
41. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649-1652, 1999
42. Ford ES: Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 155:57-64, 2002
43. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP: The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384-2389, 2001.
44. Weijers RN, Bekedam DJ, Smulders YM: Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabetes Care 25:72-77, 2002
45. Kuhnert M, Schmidt S: Changes in lymphocyte subsets during pregnancy and post-partum in cases of beginning eclampsia. J Perinat Med 28:389-398, 2000
46. Rothman KJ, Greenland S: Modern Epidemeology. Boston, MA, Little, Brown, 1998